Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03450122
Title Study of Adoptive Immunotherapy Using Autologous CD8+ NY-ESO-1-Specific T Cells and the NY-ESO-1 Immunostimulatory Agents LV305 or CMB305 For Patients With Sarcoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

myxoid liposarcoma

synovial sarcoma

Therapies

Aldesleukin + CMB305 + Cyclophosphamide + ID-LV305

Aldesleukin + Cyclophosphamide

Aldesleukin + Cyclophosphamide + ID-LV305

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.